Wave Life Sciences WVE Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Product | ||||||
| AATD Program | $6.02M+5.3% | $5.71M-17.0% | $6.89M-19.8% | $8.59M-13.4% | $9.92M-15.0% | |
| INHBE Program | $18.01M+14.6% | $15.72M+5.1% | $14.96M+15.4% | $12.97M+16.8% | $11.1M+19.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Wave Life Sciences break its business down?
- Wave Life Sciences (WVE) reports research and development expense by product across 5 parts — AATD Program, DMD Programs, HD Programs, INHBE Program and Other Research And Development Expenses Including PNPLA3Additional Preclinical Programs PRISM. Each is extracted from the segment footnotes and tracked over time.
- Where does Wave Life Sciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Wave Life Sciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
